Management of Low-Risk Prostate Cancer

Risk Assessment

• A total PSA of 0.9 ng/mL falls within the normal range (< 4.0 ng/mL) and specifically within the 0.6-1.0 ng/mL range, where prostate cancer risk is approximately 10.1% 3
• For PSA values between 0-2.5 ng/mL, the probability of cancer is approximately 1% regardless of free PSA percentage 2

Interpretation of Current Results

• The total PSA value of 0.9 ng/mL is significantly below the traditional threshold of 4.0 ng/mL that would typically trigger consideration of prostate biopsy 2
• For men with PSA values below 2.0 ng/mL, the risk of clinically significant prostate cancer is minimal, even with lower free PSA percentages 2, 3

Recommended Next Steps

• No immediate need for prostate biopsy based on current values 1, 2
• Consider digital rectal examination (DRE) at the next routine visit to complete risk assessment 1

Monitoring Considerations

• Track PSA velocity over time with annual measurements, as a rise of >0.75 ng/mL per year would be concerning 2, 3
• For men with PSA values <2.0 ng/mL, at least three PSA values over 18 months are recommended to accurately calculate PSA velocity 3

Important Caveats

• Age is an important factor in PSA interpretation - normal PSA ranges are age-specific (0-2.0 ng/mL or 0-2.5 ng/mL for men in their 40s, depending on ethnicity) 3
• Family history of prostate cancer and African-American ethnicity are risk factors that may warrant more vigilant monitoring even with low PSA values 3